Log in
Log in
The first SaaS platform dedicated to Quality by Design (ICH Q8) to boost the development of new drugs, medical devices, and analytical methods.
Log inAccording to ICH Q8(R2), Quality by design (QbD) is a proactive & scientific approach of drug development in which data-driven risk assessment methods are involved since the early design steps to optimize probabilities to meet efficacy, safety and quality specifications. FDA and EMA strongly recommend the use of QbD to fill part of the Common Technical Document, an internationally agreed format for the preparation of applications regarding new drugs intended to be submitted to regional regulatory authorities.
Log In
The main of QbD is to miminize the development timeline and costs while maximizing quality of the innovative product. Nevertheless its implementation is not "plug-and-play" if you have not the expertise in QbD and the appropriate statistical tools. easyQBD is the first digital platform developed to address this issue. The objective is to allow small and medium-sized companies to have access to this service to boost the preclinical development of their product.
Log In
easyQbD is a secured web-based platform that automatically guides non-experts through a QbD preclinical roadmap, which describes the key technical questions to be addressed to surely achieve TRL 3, 4 and 5. In each QbD study, you are accompanied by a QbD expert and a biostatistics engineer to design your experiments and analyze your data. Four reports are systematically produced to define the Quality Target Product Profile, the critical variables in formulation and manufacturing steps, their cause and effect relationships and predicted risks (design space).
Log In
ACCESS (2021-2024) Advanced Cell Control by Spectroscopic Sensors, Biomédicament : améliorer les rendements et maîtriser les coûts de production, Grand Défi Biomédicaments
EXPERT (2019-2024) EXpanding Platforms for Efficacious mRNA Therapeutics, European Union’s Horizon 2020 programme, project no. 825828
TBMED (2019-2023) A testing bed for the development of high-risk medical devices, European Union’s Horizon 2020 programme, project no. 814439
